Bone Morphogenic Protein-7의 복막섬유화 억제효과와 기전 = Antifibrotic Effect of BMP-7 in the Peritoneum and the Mechanism

다국어 초록 (Multilingual Abstract)

Purpose: Bone morphogenic protein (BMP)-7, a member of TGF-β1 superfamily, is an endogenous antifibrotic protein highly expressed in normal kidney. It is not known, however, whether human peritoneal mesothelial cells (HPMC) express BMP-7 or if BMP-7 protects against peritoneal fibrosis and by what mechanism. We examined the effect of BMP-7 overexpression in TGF-β1-induced epithelial-mesenchymal transition (EMT) of HPMC and in TGF-β1 signaling in HPMC to elucidate the mechanisms of antifibrotic effect of BMP-7. Methods: Growth arrested and synchronized HPMC were stimulated with 2 ng/mL of TGF-β1 to induce EMT. HPMC were transiently transfected with adenovirus-mediated human BMP-7 (AdBMP-7) or with GFP (AdGFP). EMT was defined as downregulation of E-cadherin and upregulation of α-smooth muscle actin (SMA). Results: HPMC constitutively expressed BMP-7 mRNA and protein. BMP-7 mRNA and protein expression were significantly inhibited by 50 mM D-glucose, 2x diluted commercial peritoneal dialysis solution, and 2 ng/ml of TGF-β1. Transfection of AdBMP-7 resulted in 2.5-fold increase in BMP-7 mRNA expression in HPMC. TGF-β1 significantly decreased E-cadherin and increased α-SMA expression in GFP transfected cells. BMP-7 overexpression effectively reversed TGF-β1-induced E-cadherin and α-SMA expression and significantly suppressed TGF-β1-induced phosphorylation of Smad2/3, ERK1/2, JNK, and p38 MAPK in HPMC as compared to GFP transfected cells. Conclusion: BMP-7 is an endogenous antifibrotic protein and downregulation of BMP-7 in HPMC by high glucose, PD solution, and TGF-β1 may permit the development of peritoneal fibrosis during long-term PD. Our data demonstrate that BMP-7 overexpression reverses TGF-β1-induced EMT of HPMC and consequent peritoneal fibrosis possibly through inhibition of Smad2/3 and MAPK phosphorylation.

참고문헌 (Reference)

1 장우석, "재조합 Bone Morphogenetic Protein-7 유전자를 이용한 골 유도" 대한정형외과학회 39 (39): 598-606, 2004

2 Hu MC, "p38 MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1" 279 : 12051-12059, 2004

3 Hayes SA, "p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion" 22 : 4841-4850, 2003

4 Lan HY, "Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells" 12 : 25-29, 2003

5 Margetts PJ, "Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum" 16 : 425-436, 2005

6 Wozney JM, "The bone morphogenetic protein family and osteogenesis" 32 : 160-167, 1992

7 Piek E, "TGF-beta type 1 receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells" 112 : 4557-4568, 1999

8 Bottinger EP, "TGF-beta signaling in renal disease" 13 : 2600-2610, 2002

9 Valcourt U, "TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition" 19 : 1987-2002, 2005

10 Li JH, "Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation" 13 : 1464-1472, 2002

11 Leivonen SK, "Smad3 mediates transforming growth factor- beta-induced collagenase-3 (matrix metalloproteinase -13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways" 277 : 46338-46346, 2002

12 Rhyu DY, "Role of reactive oxygen species in TGF- beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells" 16 : 667-675, 2005

13 Wang S, "Renal bone morphogenetic protein-7 protects against diabetic nephropathy" 17 : 2504-2512, 2006

14 Lee HB, "Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells" 65 : 1170-1179, 2004

15 Luyten FP, "Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation" 264 : 13377-13380, 1989

16 Davies SJ, "Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis" 12 : 1046-1051, 2001

17 Yanez-Mo M, "Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells" 348 : 403-413, 2003

18 Williams JD, "Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease" 13 : 470-479, 2002

19 Hruska KA, "Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction" 279 : F130-F143, 2000

20 Wozney JM, "Novel regulators of bone formation: molecular clones and activities" 242 : 1528-1534, 1988

21 Eddy AA, "Molecular insights into renal interstitial fibrosis" 7 : 2495-2508, 1996

22 Aroeira LS, "Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor" 46 : 938-948, 2005

23 Wang SN, "Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy" 12 : 2392-2399, 2001

24 Davies M, "Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP- 1 signalling pathways" 95 : 918-931, 2005

25 Ha H, "High glucose-induced PKC activation mediates TGF-beta1 and fibronectin synthesis by peritoneal mesothelial cells" 59 : 463-470, 2001

26 Vargha R, "Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents" 21 : 2943-2947, 2006

27 Iwano M, "Evidence that fibroblasts derive from epithelium during tissue fibrosis" 110 : 341-350, 2002

28 Ha H, "Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells" 22 : 171-177, 2002

29 Yang J, "Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis" 159 : 1465-1475, 2001

30 Hayashida T, "Cross- talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells" 17 : 1576-1578, 2003

31 Urist MR, "Bone: formation by autoinduction" 150 : 893-899, 1965

32 Zeisberg M, "Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models" 285 : F1060-F1067, 2003

33 Wang S, "Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy" 63 : 2037-2049, 2003

34 Chen D, "Bone morphogenetic proteins" 22 : 233-241, 2004

35 Lee MJ, "Bone morphogenetic protein-7 inhibits constitutive and interleukin-1beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway" 170 : 2557-2563, 2003

36 Wang S, "Bone morphogenetic protein- 7 signals opposing transforming growth factor beta in mesangial cells" 279 : 23200-23206, 2004

37 Zeisberg M, "BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury" 9 : 964-968, 2003

38 Saika S, "Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice" 290 : C282-C289, 2006